Search clinical trials for: immunosuppressants,

Total 43 results

Novartis

Completed

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients (CERTES02)

Organ Transplantation, Renal Transplantation
Chung Shan Medical University

Recruiting

Immunosuppressants to Postoperative Infection and Death

Cohort Study | Organ Transplantation | Immunosuppressive Agents

Taiwan
Groupe d'Etude Therapeutique des Affections Inflammatoires...
Société Nationale Française de Gastroentérologie

Completed

Early Immunosuppressants in Crohn's Disease (RAPID)

Crohn's Disease

France
Nigel E. Drury

Unknown

Pharmacology of Immunosuppressants Following Heart Transplantation

Heart Transplantation

Australia, United Kingdom
Pilloxa

Terminated

Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox

Liver Transplant; Complications | Kidney Transplant; Complications

Sweden
Novartis Pharmaceuticals

Completed

Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107

Renal Transplant
Zhongshan Ophthalmic Center, Sun Yat-sen University
The First Affiliated Hospital of Soochow University; Shandong Eye Hospital; The...

Not yet recruiting

Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis

Uveitis

China
Novartis

Completed

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

Kidney Transplant
University Hospital, Limoges

Terminated

Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation (BASALT)

Lung and Heart-lung Transplantation

Belgium, France
Novartis Pharmaceuticals

Completed

SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus

Renal Transplanted Recipients

Australia
Novartis Pharmaceuticals

Completed

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation (NOCTET)

Disorder Related to Cardiac Transplantation

Denmark, Sweden, Norway
University of Cincinnati
Astellas Pharma Inc

Completed

Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy

End Stage Renal Disease

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

Systemic Lupus Erythematosus

United States, Russian Federation, France, Spain, Korea, Republic of, Germany, Brazil, Netherlands, Canada, Mexico, Argentina
Lorenzo Gallon
Bristol-Myers Squibb

Completed

Belatacept 3 Month Post Transplant Conversion Study

EBV | Transplant; Failure, Kidney

United States
Chinese University of Hong Kong
University of Malaya

Terminated

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

Immunosuppression | Occult Hepatitis B | Biological Substance; Adverse Effect

Hong Kong
Novartis

Completed

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland, Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland
Shire

Completed

A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

Crohn's Disease | Ulcerative Colitis

Spain, United States, Korea, Republic of, Lebanon, Australia, Russian Federation, Romania, Hungary, Portugal, Israel, Italy, Turkey, Croatia, Belgium, Bulgaria, Germany, Netherlands, Poland, New Zealand, Argentina, United Kingdom, Greec... and more
CAMC Health System

Terminated

The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

Kidney Transplant Immunosuppression

United States
Assistance Publique - Hôpitaux de Paris
Immunov

Terminated

Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics (COVADIS)

Autoimmune Diseases | Inflammatory Disorder

France
University Hospital, Lille

Terminated

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants (CORhum)

Rheumatic Diseases | Rheumatoid Arthritis | Sars-CoV2

France
AbbVie

Recruiting

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Ulcerative Colitis

United States, Japan, Taiwan, Spain, Korea, Republic of, Bulgaria, Italy, Poland, France, United Kingdom, Greece, New Zealand, Australia, Belgium, Israel, Hungary, Netherlands
China National Center for Cardiovascular Diseases

Recruiting

Biomarkers of Isolated Coronary Arteritis and Related Pathogenic Mechanism

Coronary Artery Disease | Arteritis

China
University of Erlangen-Nürnberg Medical School

Recruiting

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Psoriatic Arthritis | Withdrawal | Reduction

Germany
Centre Hospitalier Universitaire de Saint Etienne
Pfizer

Terminated

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD (PneumoMICI)

Bowel Diseases, Inflammatory | Infections, Pneumococcal

France
Novartis

Completed

Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients

Liver Transplant
University Hospital Muenster
Hoffmann-La Roche

Completed

Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

Bullous Pemphigoid

Germany
The Second Affiliated Hospital of Chongqing Medical...

Recruiting

Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients

Kidney Transplantation | Immunosuppressive Agents

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Tang-Du Hospital

Recruiting

TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study (TREAT-OMG)

Ocular Myasthenia Gravis

China
Grupo Espanol de Trabajo en Enfermedad de Crohn...
Abbott; TFS Trial Form Support

Terminated

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants (ADACAL)

Crohn's Disease | Mucosal Inflammation

Spain, France, Belgium
Tibotec Pharmaceuticals, Ireland

Completed

A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

Hepatitis C Virus

Belgium
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy

Non-infectious Uveitis
AstraZeneca
CernerEnviza / Oracle

Recruiting

Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs. (ERYTHRO)

Systemic Lupus Erythematosus

United Kingdom, Portugal, Israel, France, Greece, Spain, Italy
AstraZeneca
Parexel

Recruiting

A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice (ASTER)

Systemic Lupus Erythematosus

Italy, Belgium, Germany, France, Canada, Austria, Sweden, Denmark, Israel, United Arab Emirates
Novartis Pharmaceuticals

Completed

Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms (PROGIS)

Kidney Transplantation | GI Symptoms Severity

Malaysia
National Institute of Allergy and Infectious Diseases...
Rho Federal Systems Division, Inc.; Clinical Trials in Organ Transplantation...

Completed

Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction (ARTEMIS)

Liver Transplant Recipient | Living Donor (of the Respective Liver Transplant Recipient)

United States
AstraZeneca

Recruiting

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) (DAISY)

Systemic Sclerosis | Scleroderma

United Kingdom, United States, Italy, Mexico, Belgium, Germany, Spain, China, France, India, Austria, Canada, Poland, Israel, Korea, Republic of, Hungary, Japan, South Africa, Turkey, Netherlands, Romania
Eli Lilly and Company

Completed

A Study of LY2127399 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus | Autoimmune Disease | Connective Tissue Disease

Argentina, Italy, Korea, Republic of, United States, Bulgaria, Ukraine, Colombia, Philippines, Austria, Japan, Belarus, Canada, Chile, Croatia, Egypt, Germany, Guatemala, Macedonia, The Former Yugoslav Republic of, Peru, Poland, Puerto Rico and more
Hospital Mutua de Terrassa

Completed

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study (MIC project)

Inflammatory Bowel Diseases | Hepatitis C Virus Infection

Spain
Guang'anmen Hospital of China Academy of Chinese...
China Academy of Chinese Medical Sciences

Active, not recruiting

Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD (TCMWINE)

IgA Nephropathy at High Risk of Developing ESRD

China

Search clinical trials for: immunosuppressants,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations